Hemispherx BioPharma (HEB)

[STOCK_MOMO]

Hemispherx BioPharma, Inc. (NYSE-MKT: HEB) is an advanced specialty pharmaceutical company. Hemispherx's flagship products include Alferon N Injection(R) and the experimental therapeutics Ampligen(R) and Alferon(R) LDO. Ampligen(R) is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system, including Chronic Fatigue Syndrome. Hemispherx's platform technology includes components for potential treatment of various severely debilitating and life threatening diseases.